[
    {
        "other_ids": [],
        "amendment_date": null,
        "keywords": [
            "T-cell therapy",
            "immunotherapy"
        ],
        "dcp_id": null,
        "interventional_model": "Parallel",
        "lead_org": "Immatics US, Inc.",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Pathologically confirmed advanced and/or metastatic solid tumor"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Patients may enter screening procedure before, during, or after the last available indicated standard of care treatment. There is no limitation for prior anti cancer treatments."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "Eastern Cooperative Oncology Group (ECOG) performance status 0-1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "HLA phenotype positive for the study"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "Measurable disease and accessible to biopsy"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "Adequate pulmonary function per protocol"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "Adequate organ and bone marrow function per protocol"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "Acceptable coagulation status per protocol"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "Adequate hepatic function per protocol"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "Adequate renal function per protocol"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 10,
                    "description": "Patient's tumor must express tumor antigen by qPCR using a fresh tumor biopsy specimen"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 11,
                    "description": "Life expectancy more than 3 months"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 12,
                    "description": "Confirmed availability of production capacities for IMA203 product"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 13,
                    "description": "Patients must have recurrent/progressing and/or refractory solid tumors and must have received or not be eligible for all available indicated standard of care treatment."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 14,
                    "description": "For hepatocellular carcinoma (HCC) patients only, Child-Pugh score of \u2264 6"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 15,
                    "description": "IMA203 product must have passed all of the release tests"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 16,
                    "description": "Female patient of childbearing potential must use adequate contraception prior to study entry until 12 months after the infusion of IMA203"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 17,
                    "description": "Male patient must agree to use effective contraception or be abstinent while on study and for 6 months after the infusion of IMA203"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 18,
                    "description": "Hepatocellular carcinoma (HCC) patients with liver cirrhosis only - upper endoscopy is required within 6 months of study entry"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 19,
                    "description": "The patient must have recovered from any side effects of prior therapy to Grade 1 or lower (except for non-clinically significant toxicities; e.g., alopecia, vitiligo) prior to lymphodepletion. As determined by the investigator, the patient may still be eligible if the patient has not fully recovered from Grade \u2265 2 toxicities if these toxicities are not anticipated to further improve (e.g., chronic neuropathy) and such toxicities are not anticipated to worsen with the lymphodepletion therapy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 20,
                    "description": "History of other malignancies (except for adequately treated basal or squamous cell carcinoma or carcinoma in situ) within the last 3 years"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 21,
                    "description": "Solid tumors with low likelihood of tumor biomarker expression per protocol"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 22,
                    "description": "Pregnant or breastfeeding"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 23,
                    "description": "Serious autoimmune disease Note: At the discretion of the investigator, these patients may be included if their disease is well controlled without the use of immunosuppressive agents."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 24,
                    "description": "History of cardiac conditions as per protocol"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 25,
                    "description": "Prior stem cell transplantation or solid organ transplantation"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 26,
                    "description": "Concurrent severe and/or uncontrolled medical disease that could compromise participation in the study"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 27,
                    "description": "History of hypersensitivity to cyclophosphamide (CY), fludarabine (FLU), or IL-2 or any of these rescue medications"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 28,
                    "description": "History of or current immunodeficiency disease or prior treatment compromising immune function at the discretion of the treating physician"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 29,
                    "description": "HIV infection, active hepatitis B virus (HBV), active hepatitis C virus (HCV) infection, ongoing active anti-HCV treatment or detectable HBV or HCV viral load at the most recent laboratory report. Patients with both HBV and HCV infections will be excluded from screening"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 30,
                    "description": "Patients with a history of HCV infection and with an undetectable viral load per the most recent laboratory report and/or completed anti-HCV treatment but are HCV antibody positive are permitted."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 31,
                    "description": "History of treated HBV infection is permitted if the viral load is undetectable per the most recent laboratory report. Note: HCC patients with controlled HBV infection, as defined by resolved (anti-hepatitis B surface antigen [HBs-Ag] antibody (Ab) negative, anti-core antigen [HBc Ag] Ab positive) or chronic stable (anti HBs-Ag Ab positive) HBV infection will be eligible for screening. Patients with active HBV infection who are not on anti-HBV treatment will be excluded."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 32,
                    "description": "Any condition contraindicating leukapheresis, lymphodepletion, low-dose IL-2, and/or IMA203 treatment"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 33,
                    "description": "Patients with active brain metastases NOTE: Patients with a history of brain metastases may be eligible, if an imaging scan with contrast enhancement not older than 4 weeks is able to exclude the existence of currently active brain metastasis, and steroid therapy has been discontinued for \u22652 weeks."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 34,
                    "description": "Treatment with protocol-defined excluded treatments, medical devices, and/or procedures per protocol"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 35,
                    "description": "Concurrent participation in an interventional part of another clinical trial."
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "SCREENING: Patient eligibility will be determined by protocol inclusion/exclusion criteria\r\n      including HLA (human leukocyte antigen) screening and a biopsy for biomarker screening. If\r\n      the patient is eligible, white blood cells will be taken during leukapheresis for the\r\n      manufacture of the IMA203 product.\r\n\r\n      MANUFACTURING: IMA203 product will be made from the patient's white blood cells.\r\n\r\n      TREATMENT: Lymphodepletion with cyclophosphamide and fludarabine will occur in the days\r\n      before the IMA203 product infusion to improve the duration of time that IMA203 product stays\r\n      in the body. The patient will be admitted to the hospital during the T-cell infusion.\r\n\r\n      After the IMA203 product infusion, a low dose of IL-2 will be given subcutaneously daily for\r\n      10 days.\r\n\r\n      In Extension Cohort B (IMA203 plus atezolizumab), atezolizumab will be administered for up to\r\n      one year.\r\n\r\n      Patients will be monitored closely throughout the study. The treatment and observation phase\r\n      ends 3 years post infusion.",
        "official_title": "Phase 1 Study Evaluating Genetically Modified Autologous T Cells Expressing a TCR Recognizing a Cancer/Germline Antigen as Monotherapy or in Combination With Atezolizumab in Patients With Recurrent and/or Refractory Solid Tumors",
        "_phase_sort_order": 4,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "up to 3 years post treatment",
                "name": "Incidence of adverse events (AE)",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "up to 3 years post treatment",
                "name": "Persistence of T-cells",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "up to 12 months",
                "name": "Tumor response per Response Evaluation Criteria In Solid Tumors (RECIST) 1.1 and immune-related RECIST (irRECIST)",
                "description": null,
                "type_code": "SECONDARY"
            }
        ],
        "phase": "I",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 3,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT03686124",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "HLA Positive",
                    "Human Leukocyte Antigen Phenotype Positive",
                    "Human Leukocyte Antigen Positive"
                ],
                "nci_thesaurus_concept_id": "C154157",
                "name": "HLA Phenotype Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C35682",
                    "C36292",
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C35682"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Positive",
                    "positive test result"
                ],
                "nci_thesaurus_concept_id": "C35682",
                "name": "Positive Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C77140"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2019-05-01",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Recurrent Malignant Solid Neoplasm",
                    "Recurrent Solid Neoplasm",
                    "Relapsed Solid Tumor",
                    "Recurrent Solid Tumor",
                    "Relapsed Malignant Solid Neoplasm",
                    "Relapsed Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C127153",
                "name": "Recurrent Malignant Solid Tumor",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C132146",
                    "C4813"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Solid Neoplasm",
                    "Metastatic Solid Tumor",
                    "Metastatic Tumor",
                    "Metastatic Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C127155",
                "name": "Metastatic Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C132146"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Advanced Malignant Solid Neoplasm",
                    "Advanced Non-Hematologic Malignancy",
                    "Advanced Solid Neoplasm",
                    "Advanced Solid Tumor"
                ],
                "nci_thesaurus_concept_id": "C129707",
                "name": "Advanced Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C127155",
                    "C9270"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C133737",
                "name": "Refractory Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C120186",
                    "C132146"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "CARCINOMA, HEPATOCELLULAR, MALIGNANT",
                    "Hepatocellular Carcinoma",
                    "Carcinoma of the Liver Cells",
                    "Liver Cell Carcinoma",
                    "LIHC",
                    "Carcinoma of Liver Cells",
                    "HCC",
                    "Hepatoma",
                    "Primary Carcinoma of the Liver Cells",
                    "Primary Carcinoma of Liver Cells",
                    "Liver Cell Cancer (Hepatocellular Carcinoma)"
                ],
                "nci_thesaurus_concept_id": "C3099",
                "name": "Hepatocellular Cancer",
                "type": [
                    "maintype",
                    "subtype"
                ],
                "parents": [
                    "C2852",
                    "C7927"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasms, NOS",
                    "Neoplasia",
                    "Tumor, NOS",
                    "Neoplastic Growth",
                    "Neoplasm",
                    "Neoplastic Disease",
                    "tumor",
                    "Neoplasm, NOS"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Recurrence",
                    "Recurrent",
                    "Recurrent Tumor",
                    "Neoplasm Recurrence"
                ],
                "nci_thesaurus_concept_id": "C4798",
                "name": "Recurrent Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Solid Tumour",
                    "Solid tumor, NOS",
                    "Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C9292",
                "name": "Solid Tumor",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Malignant Growth",
                    "Tumor, malignant, NOS",
                    "Malignant Tumor",
                    "Malignancy",
                    "CA",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C132146",
                "name": "Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9292",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Recurrence",
                    "Recurrent Cancer",
                    "Recurrent Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C4813",
                "name": "Recurrent Malignant Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C9305",
                    "C4798"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Disease",
                    "Diseases and Disorders",
                    "disease type",
                    "Disease or Disorder",
                    "Diagnosis",
                    "disease_term",
                    "condition",
                    "disease_type",
                    "Diseases",
                    "Disease or Disorder, Non-Neoplastic",
                    "Disorders",
                    "Disorder"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "resistant cancer",
                    "Refractory Cancer",
                    "clinical resistance"
                ],
                "nci_thesaurus_concept_id": "C120186",
                "name": "Refractory Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C7628"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Liver and Biliary System Neoplasm",
                    "Malignant Liver and Biliary Neoplasm",
                    "Malignant Hepato-Biliary Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8609",
                "name": "Malignant Hepatobiliary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4890",
                    "C8614"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Gastrointestinal System Neoplasm",
                    "Gastrointestinal cancer, NOS",
                    "Gastrointestinal System Cancer",
                    "Malignant Digestive System Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C4890",
                "name": "Malignant Gastrointestinal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C3052"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Hepatic and Biliary Neoplasms",
                    "Hepato-Biliary Neoplasm",
                    "Liver and Biliary Neoplasm",
                    "Hepato-Biliary Tumor",
                    "Liver and Biliary System Neoplasm",
                    "Hepatic, Biliary, and Gallbladder Neoplasms",
                    "Hepatic and Biliary Tumors",
                    "Hepatobiliary Tumors",
                    "Hepatobiliary Tumor"
                ],
                "nci_thesaurus_concept_id": "C8614",
                "name": "Hepatobiliary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3052",
                    "C3959"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Tumor"
                ],
                "nci_thesaurus_concept_id": "C7628",
                "name": "Refractory Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Gastrointestinal System Disorder",
                    "Unspecified Gastrointestinal Problem",
                    "Disorder of Digestive System",
                    "stomach or intestinal disorder",
                    "GI Disorder",
                    "Gastrointestinal Disorder",
                    "Digestive System Disease",
                    "Gastrointestinal System Disease",
                    "Digestive Disease"
                ],
                "nci_thesaurus_concept_id": "C2990",
                "name": "Digestive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Hepatic and Intrahepatic Bile Duct Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7103",
                "name": "Liver and Intrahepatic Bile Duct Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3196",
                    "C8614"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Liver Disorder",
                    "Liver Disease",
                    "Hepatic Disorder"
                ],
                "nci_thesaurus_concept_id": "C3196",
                "name": "Liver and Intrahepatic Bile Duct Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3959"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Carcinoma of the Gastrointestinal System",
                    "Gastrointestinal System Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C96963",
                "name": "Digestive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C4890"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor of GI System",
                    "Tumor of Digestive System",
                    "Digestive Tumor",
                    "GI Neoplasm",
                    "Neoplasm of the Gastrointestinal System",
                    "Digestive System Tumor",
                    "Gastrointestinal Tumor",
                    "Neoplasm of the Digestive System",
                    "Tumor of the Gastrointestinal System",
                    "Neoplasm of Digestive System",
                    "Tumor of the Digestive System",
                    "Gastrointestinal System Tumor",
                    "Gastrointestinal Neoplasm",
                    "GI Tumor",
                    "Tumor of Gastrointestinal System",
                    "Gastrointestinal System Neoplasm",
                    "Neoplasm of the GI System",
                    "GI System Tumor",
                    "GI System Neoplasm",
                    "Neoplasm of Gastrointestinal System",
                    "Tumor of the GI System",
                    "Digestive Neoplasm",
                    "Neoplasm of GI System"
                ],
                "nci_thesaurus_concept_id": "C3052",
                "name": "Digestive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3263",
                    "C2990"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Tumor",
                    "Tumor, metastatic",
                    "Neoplasm, metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor Morphology",
                    "Tumor_Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Glandular Cell Epithelium Neoplasm",
                    "Glandular Cell Epithelial Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7132",
                "name": "Glandular Cell Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Liver and Biliary System Disorder",
                    "Liver and Biliary Disease",
                    "Liver and Biliary Disorder",
                    "Liver Disease"
                ],
                "nci_thesaurus_concept_id": "C3959",
                "name": "Hepatobiliary Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2990"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Advanced Cancer"
                ],
                "nci_thesaurus_concept_id": "C9270",
                "name": "Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Cancer of the Liver",
                    "Liver Carcinoma",
                    "Liver/hepatobiliary cancer",
                    "Cancer of Liver",
                    "Liver and hepatobiliary cancer, NOS",
                    "Liver and Intrahepatic Biliary Tract Cancer",
                    "Cancer of the Liver and Intrahepatic Biliary Tract",
                    "Liver and Intrahepatic Bile Duct Carcinoma",
                    "Liver and Intrahepatic Bile Duct Cancer",
                    "Cancer of Liver and Intrahepatic Biliary Tract",
                    "Liver and Intrahepatic Biliary Tract Carcinoma",
                    "Biliary Tract Cancer",
                    "Primary Liver Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C7927",
                "name": "Liver Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C34803",
                    "C7106",
                    "C96963"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm, secondary",
                    "Secondary Tumor",
                    "Tumor, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Epithelial Hepatic and Intrahepatic Bile Duct Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7106",
                "name": "Liver and Intrahepatic Bile Duct Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7103"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Secondary Malignancy",
                    "Secondary Cancer"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C36255"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Primary Malignant Neoplasm of Liver"
                ],
                "nci_thesaurus_concept_id": "C34803",
                "name": "Primary Malignant Liver Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8609",
                    "C7103"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Adenocarcinoma, NOS",
                    "ADENOCARCINOMA, MALIGNANT"
                ],
                "nci_thesaurus_concept_id": "C2852",
                "name": "Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C7132"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Malignant Epithelial Neoplasm",
                    "Epithelial Carcinoma",
                    "Malignant Epithelioma",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Epithelial tumor, malignant",
                    "Epithelioma Malignant"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C3709",
                    "C9305"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "IMA203-101",
        "active_sites_count": 3,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "T-Cell Growth Factor",
                            "Interleukin-2",
                            "Lymphocyte Mitogenic Factor",
                            "Interleukin II",
                            "Mitogenic Factor",
                            "Thymocyte Stimulating Factor"
                        ],
                        "nci_thesaurus_concept_id": "C587",
                        "name": "Recombinant Interleukin-2",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C593"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunomodulators",
                            "BRM",
                            "Immune Regulators",
                            "Immunomodulatory Agent",
                            "Immunotherapeutic Agent",
                            "Biomodulators",
                            "Immune Modulators",
                            "Immunopotentiators",
                            "Biological Response Modifier",
                            "Immunomodulating Agent",
                            "Immunotherapy Agent",
                            "Immune Mediators"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Chemotherapy Alkylating Agents",
                            "Chemotherapy Alkylators"
                        ],
                        "nci_thesaurus_concept_id": "C1590",
                        "name": "Antineoplastic Alkylating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2842"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Interleukins"
                        ],
                        "nci_thesaurus_concept_id": "C593",
                        "name": "Recombinant Interleukin",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1283"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C141144",
                        "name": "Immune Checkpoint Modulator",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "ACT Agent",
                            "Adoptive Cellular Therapy Agent",
                            "Adoptive Cell Therapy Agent",
                            "Adoptive Cell-based Agent",
                            "Adoptive Cell Transfer Agent"
                        ],
                        "nci_thesaurus_concept_id": "C142078",
                        "name": "Adoptive Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C307",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biopharmaceuticals",
                            "Immunologics",
                            "Biologicals",
                            "Immunologic, Immunochemical",
                            "Biologics",
                            "Biological Products"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Gene Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1962",
                        "name": "Gene Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antimetabolites"
                        ],
                        "nci_thesaurus_concept_id": "C272",
                        "name": "Antimetabolite",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2150",
                        "name": "Ribonucleotide Reductase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C143250",
                        "name": "Immune Checkpoint Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C141144"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Cell-based Gene Therapy Agent",
                            "Genetically-altered Immune Cell",
                            "Genetically-modified Immune Cell"
                        ],
                        "nci_thesaurus_concept_id": "C154231",
                        "name": "Genetically-engineered Immune Cell",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1962",
                            "C142078"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biopharmaceuticals",
                            "Immunologics",
                            "Biologicals",
                            "Immunologic, Immunochemical",
                            "Biologics",
                            "Biological Products"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Purine Inhibitors"
                        ],
                        "nci_thesaurus_concept_id": "C1556",
                        "name": "Purine Antagonist",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C272"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Diagnostic, Therapeutic, and Research Equipment",
                            "Equipment",
                            "Hardware"
                        ],
                        "nci_thesaurus_concept_id": "C19238",
                        "name": "Diagnostic, Therapeutic, or Research Equipment",
                        "description": null,
                        "type": "Device",
                        "category": "other",
                        "parents": [
                            "C97325"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Biotherapeutic",
                            "Anti-cancer Biological Agent",
                            "Antineoplastic Biological",
                            "Anticancer Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Cytokines"
                        ],
                        "nci_thesaurus_concept_id": "C1283",
                        "name": "Recombinant Cytokine",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C307",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-tumor Targeted Therapy Agent",
                            "Molecularly Targeted Therapy Agent",
                            "Targeted Therapeutic Agent",
                            "Targeted Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibody",
                            "Monoclonal Antibodies"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C307",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2842",
                        "name": "DNA Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Inhibitor Agent",
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Drug"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C697",
                        "name": "Nitrogen Mustard Compound",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2114"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C161835",
                        "name": "IMADetect",
                        "description": null,
                        "type": "Device",
                        "category": "other",
                        "parents": [
                            "C16830"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunosuppressive Agents"
                        ],
                        "nci_thesaurus_concept_id": "C574",
                        "name": "Immunosuppressant",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "T-cell Receptor-engineered T-lymphocytes",
                            "TCR T Cells",
                            "TCR T-cells",
                            "T-cell Receptor-engineered T Cells",
                            "TCR-modified T Cells",
                            "TCR-engineered T-cells"
                        ],
                        "nci_thesaurus_concept_id": "C138180",
                        "name": "T-cell Receptor-engineered T-cells",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C154231"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Drug",
                            "Agent",
                            "Drug Substance",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals",
                            "Pharmacologic Agent",
                            "Pharmacological Substance"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Tecentriq"
                        ],
                        "nci_thesaurus_concept_id": "C106250",
                        "name": "Atezolizumab",
                        "description": "A human, Fc optimized, monoclonal antibody directed against the protein ligand PD-L1 (programmed cell death-1 ligand 1) with potential immunomodulating and antineoplastic activities. Anti-PD-L1 monoclonal antibody MPDL3280A binds to PD-L1, blocking its binding to and activation of its receptor, PD-1 (programmed death 1), which may enhance the T-cell-mediated immune response to neoplasms and reverse T-cell inactivation. In addition, by binding to PD-L1, MPDL3280A also prevents binding of this ligand to B7.1. PD-L1 is overexpressed on many human cancer cell types. PD-L1 binding to PD-1 on T-cells suppresses the immune system and results in increased immune evasion. PD-1, a transmembrane protein expressed on activated T-cells, is a negative regulator of the immune system that limits the expansion and survival of CD8+ T cells. The Fc region of MPDL3280A is modified in such a way that it does not induce either antibody-dependent cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC)",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C128057"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C128057",
                        "name": "Anti-PD-L1 Monoclonal Antibody",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C156893",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Antineoplastic Immunotherapeutic",
                            "Anti-cancer Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C161831",
                        "name": "Autologous TCR-engineered T-cells IMA203",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C129826",
                            "C28681",
                            "C138180"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Genoxal",
                            "Cyclostine",
                            "Cicloxal",
                            "Carloxan",
                            "Cycloblastine",
                            "CYCLO-cell",
                            "Cycloblastin",
                            "Ledoxina",
                            "Cytophosphan",
                            "Cyclostin",
                            "Genuxal",
                            "Fosfaseron"
                        ],
                        "nci_thesaurus_concept_id": "C405",
                        "name": "Cyclophosphamide",
                        "description": "A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C574",
                            "C697"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Drug",
                            "Agent",
                            "Drug Substance",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals",
                            "Pharmacologic Agent",
                            "Pharmacological Substance"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunomodulators",
                            "BRM",
                            "Immune Regulators",
                            "Immunomodulatory Agent",
                            "Immunotherapeutic Agent",
                            "Biomodulators",
                            "Immune Modulators",
                            "Immunopotentiators",
                            "Biological Response Modifier",
                            "Immunomodulating Agent",
                            "Immunotherapy Agent",
                            "Immune Mediators"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Tumor Agents",
                            "Antiproliferative Agents",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Tumor-Specific Treatment Agents",
                            "Antiproliferative Drugs",
                            "Cancer Drug",
                            "Anti-Tumor Drugs",
                            "Anti-Cancer Agents",
                            "Antineoplastics",
                            "Antineoplastic Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Device",
                            "Medical Devices"
                        ],
                        "nci_thesaurus_concept_id": "C16830",
                        "name": "Medical Device",
                        "description": null,
                        "type": "Device",
                        "category": "other",
                        "parents": [
                            "C62103"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Immune Cell",
                            "Antineoplastic Immune Cells"
                        ],
                        "nci_thesaurus_concept_id": "C129826",
                        "name": "Antineoplastic Immune Cell",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129821",
                            "C142078",
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1094",
                        "name": "Fludarabine",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2150",
                            "C1556"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Tumor Agents",
                            "Antiproliferative Agents",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Tumor-Specific Treatment Agents",
                            "Antiproliferative Drugs",
                            "Cancer Drug",
                            "Anti-Tumor Drugs",
                            "Anti-Cancer Agents",
                            "Antineoplastics",
                            "Antineoplastic Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Autologous T-cells"
                        ],
                        "nci_thesaurus_concept_id": "C28681",
                        "name": "Therapeutic Autologous Lymphocytes",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C142078"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Proleukin"
                        ],
                        "nci_thesaurus_concept_id": "C1498",
                        "name": "Aldesleukin",
                        "description": "A recombinant analog of the endogenous cytokine interleukin-2 (IL-2) with immunoregulatory and antineoplastic activities. Aldesleukin binds to and activates the IL-2 receptor, followed by heterodimerization of the cytoplasmic domains of the IL-2R beta and gamma(c) chains; activation of the tyrosine kinase Jak3; and phosphorylation of tyrosine residues on the IL-2R beta chain, resulting in an activated receptor complex. Various cytoplasmic signaling molecules are recruited to the activated receptor complex and become substrates for regulatory enzymes that are associated with the receptor complex. This agent enhances lymphocyte mitogenesis; stimulates long-term growth of human IL-2 dependent cell lines; enhances lymphocyte cytotoxicity; induces lymphokine-activated killer (LAK) cell and natural killer (NK) cell activities; and induces expression of interferon-gamma. Aldesleukin may induce T cell-mediated tumor regression in some tumor types. Check for active clinical trials or closed cli",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C587"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "PD-1 Ligand-targeting Agent",
                            "PD-1 Ligands Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C156893",
                        "name": "PD-1 Ligand Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C143250"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C62103",
                        "name": "Device",
                        "description": null,
                        "type": "Device",
                        "category": "other",
                        "parents": [
                            "C19238"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2114",
                        "name": "Mustard Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1590"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C97325",
                        "name": "Manufactured Object",
                        "description": null,
                        "type": "Device",
                        "category": "other",
                        "parents": []
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "Dose Escalation",
                "description": "Dose escalation of IMA203",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Extension Cohort A",
                "description": "IMA203 at MTD",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Extension Cohort B",
                "description": "IMA203 at MTD + atezolizumab",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2019-03808",
        "why_study_stopped": null,
        "brief_summary": "The study purpose is to establish the safety and tolerability of IMA203 product with or\r\n      without combination with atezolizumab in patients with solid tumors that express\r\n      preferentially expressed antigen in melanoma (PRAME).",
        "brief_title": "TCR-engineered T Cells in Solid Tumors",
        "status_history": [
            {
                "status_date": "2019-05-01T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 42,
        "_current_trial_status_sort_order": 0,
        "start_date": "2019-05-14",
        "record_verification_date": "2021-08-01",
        "ctep_id": null,
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Non-Randomized Trial"
        },
        "acronym": "ACTengine",
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Multiple"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2024-01-01",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]